NeuroSense Therapeutics (NRSNW) Q3 2024 Earnings

Sep 30Confirmed
Mar 2021
Jun 2021
Q2 2024
Q3 2024
-0.35
-0.23
-0.12
0

Details

Expected EPS
-0.185
Actual EPS
-0.05
Surprise EPS
0.14
Surprise Percent
+72.97%

Description

⁨NeuroSense Therapeutics⁩ (⁦NRSNW⁩) has reported earnings of ⁦-0.05⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts